Synthesis 2025; 57(02): 389-396
DOI: 10.1055/s-0043-1775411
paper
Special Topic Dedicated to Prof. H. Ila

Facile Synthesis of New Antiviral Fluoro-Quinazolines Enabled by Merging Domino Reactions

a   Department of Organic Chemistry I, FAU Erlangen-Nürnberg, Nikolaus-Fiebiger-Straße 10, 91058 Erlangen, Germany
,
Honglin Xia
a   Department of Organic Chemistry I, FAU Erlangen-Nürnberg, Nikolaus-Fiebiger-Straße 10, 91058 Erlangen, Germany
,
Benedikt W. Grau
a   Department of Organic Chemistry I, FAU Erlangen-Nürnberg, Nikolaus-Fiebiger-Straße 10, 91058 Erlangen, Germany
,
Christina Wangen
b   Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Schlossgarten 4, 91054 Erlangen, Germany
,
Friedrich Hahn
b   Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Schlossgarten 4, 91054 Erlangen, Germany
,
Valentine G. Nenajdenko
c   Faculty of Chemistry, Lomonosov Moscow State University, Moscow, Russian Federation
,
Manfred Marschall
b   Institute of Clinical and Molecular Virology, Universitätsklinikum Erlangen, Schlossgarten 4, 91054 Erlangen, Germany
,
a   Department of Organic Chemistry I, FAU Erlangen-Nürnberg, Nikolaus-Fiebiger-Straße 10, 91058 Erlangen, Germany
› Institutsangaben
S.B.T. gratefully acknowledges the financial support by the grant from Deutsche Forschungsgemeinschaft TS 87/28-1.


In honor of Professor H. Ila’s 80th anniversary

Abstract

Quinazolines, particularly fluoro-quinazolines, represent important structural motifs in bioactive molecules and pharmaceuticals. Despite several known synthetic routes, the efficient synthesis of fluorine-containing quinazolines remains a challenge. Herein, the straightforward and sustainable synthesis of fluorine-substituted quinazolines using domino sequences is reported. The obtained novel fluoro-quinazoline compounds exhibit significant in vitro activity against human cytomegalovirus (HCMV), expanding the library of potential antiviral drug compounds. Our finding outlays the synthetic toolkit for fluoro-quinazolines and introduces new agents for HCMV therapy.

Supporting Information



Publikationsverlauf

Eingereicht: 05. Juni 2024

Angenommen nach Revision: 18. September 2024

Artikel online veröffentlicht:
12. November 2024

© 2024. Thieme. All rights reserved

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany